To increase the chances of detecting azathioprine-related mutations, we therefore chose to examine more NSE BCC from the Aza group (the ratio of SE to NSE tumours in the Aza group was approximately 1 : 1 compared with 4 : 1 in the non-Aza group). This evidence concerns the gene ENO2 and skin basal cell carcinoma.